Cara Therapeutics | CARA - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Assertio Holdings USD 38.5M 8.59M 2025-09
Cara Therapeutics USD 20.73M 684K 2025-12
Cassava Sciences USD 86.57M 8.93M 2026-03
Chugai Pharma JPY 426.6B 29.83B 2025-12
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 309.75M 175.93M 2026-03
J&J USD 21.69B 1.98B 2026-03
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Pacira USD 144.31M 14.24M 2026-03
Pfizer USD 1.7B 561M 2026-03
RedHill Biopharma USD 2.87M 1.75M 2025-06
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12